HIV INFEKSIYASINI DAVOLASHDA SO‘NGGI YUTUQLAR VA ZAMONAVIY USULLAR
PDF

Keywords

OIV, antiretrovirus terapiya, integraza inhibitörlari, gen terapiyasi, CRISPR, uzoq ta’sir qiluvchi dori, latent rezervuar, immunoterapiya

Abstract

OIV (inson immun tanqisligi virusi) infeksiyasi global sog‘liqni saqlash muammosi bo‘lib, so‘nggi o‘n yilliklarda virusning replikatsiyasini bostirishga qaratilgan antiretrovirus terapiya (ART) orqali minglab insonlarning hayoti saqlab qolindi. Zamonaviy ART protokollari yuqori samaradorlik, past toksiklik va uzoq muddatli nazoratga asoslangan bo‘lib, bemorlarning virus yukini aniqlanmaydigan darajaga tushirish va CD4 hujayralar sonini barqarorlashtirishga xizmat qilmoqda. Yaqinda ishlab chiqilgan uzoq ta’sir qiluvchi inyektsion preparatlar, ikki komponentli kombinatsiyalar, va CRISPR-Cas9 asosida genetik terapiya prototiplari HIVni to‘liq davolash istiqbollarini ochib bermoqda. Shuningdek, immunoterapiya va terapevtik vaksinatsiya yo‘nalishidagi tadqiqotlar virusning yashirin rezervuarlarini yo‘qotishga qaratilgan innovatsion yondashuvlarni taqdim etmoqda.

PDF

References

1. UNAIDS. Global HIV & AIDS statistics — Fact sheet. 2024.

2. World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring. Geneva, 2021.

3. Deeks SG, Lewin SR, Bekker LG, et al. “International AIDS Society global scientific strategy: Towards an HIV cure 2021.” Nature Medicine, 27(12), 2021, 2085–2098.

4. Margolis DM, Garcia JV, Hazuda DJ, et al. “Latent HIV Infection and the Prospect of a Cure.” Nature Reviews Microbiology, 2020; 18: 215–229.

5. Fidler S, Stöhr W, Pace M, et al. “Antiretroviral therapy initiation within days of HIV diagnosis in adults: A randomized controlled trial.” The Lancet HIV, 2022; 9(1): e10–e20.

6. Gaebler C, Nogueira L, Oliveira TY, et al. “Prolonged viral suppression with anti-HIV-1 antibody therapy.” Nature, 2022; 606(7915): 368–374.

7. Tebas P, Stein D, Tang WW, et al. “Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.” New England Journal of Medicine, 2014; 370: 901–910.

8. Sneller MC, Justement JS, Gittens K, et al. “Therapeutic vaccine and bNAb in chronic HIV-1 infection.” Nature Medicine, 2023; 29(1): 57–65.

9. Sahin U, Muik A, Vogler I, et al. “mRNA-based therapeutic vaccines against HIV: Advances and challenges.” Cell, 2023; 186(1): 9–23.

10. NIH Clinical Trials Database. clinicaltrials.gov. Accessed July 2025.